Clinical Outcome of Female Non-gastric Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumor Clinical Trial

Official title:

Far Eastern Memorial Hospital

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04256226
• Other study ID #: 108174-E
• Status: Completed
• Start date: February 1, 2020
• Est. completion date: March 31, 2020

Study information

• Verified date: March 2020
• Source: Far Eastern Memorial Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To elucidate the prognosis of women with non-gastric primary gastrointestinal stromal tumors.

Description:

Gastrointestinal stromal tumor (GIST) are mesenchymal tumors arising from gastrointestinal tract, mesentery, or omentum. They took up about 3% of gastrointestinal malignancies. Although rarely, the clinical presentation of non-gastric GIST might mimick ovarian cancer, and would be managed by gynecologists. Therefore, retrospective review of female non-gastric GIST cases will be performed to investigate the clinical outcome of non-gastric GIST. The result of this study might be used as an important reference for gynecologists.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: March 31, 2020
• Est. primary completion date: March 31, 2020
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• > 20 years of women.

• non-gastric gastrointestinal stromal tumor

Exclusion Criteria:

• Those without pathological report or surgical record.

Related Conditions & MeSH terms

• Gastrointestinal Stromal Tumor
• Gastrointestinal Stromal Tumors

Intervention

Procedure:
• Tumor excision
Excision of GIST

Locations

Country	Name	City	State
Taiwan	Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital	Banqiao	New Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Far Eastern Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall survival	The date of surgery to the date of death or last follow-up	20 years
Secondary	Recurrence-free survival	The date of surgery to the date of recurrence or last follow-up	20 years